Bausch Health Cos Profit Margin 2010-2023 | BHC

Current and historical gross margin, operating margin and net profit margin for Bausch Health Cos (BHC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Bausch Health Cos net profit margin as of December 31, 2023 is -6.76%.
Bausch Health Cos Annual Profit Margins
Bausch Health Cos Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.128B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.585B 5.27
Dr Reddy's Laboratories (RDY) India $11.835B 18.71
Aspen Pharmacare (APNHY) South Africa $4.900B 0.00
BridgeBio Pharma (BBIO) United States $4.401B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.004B 13.71
Supernus Pharmaceuticals (SUPN) United States $1.656B 0.00
Taysha Gene Therapies (TSHA) United States $0.439B 0.00
Generation Bio (GBIO) United States $0.199B 0.00
Assembly Biosciences (ASMB) United States $0.074B 0.00
Personalis (PSNL) United States $0.066B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.026B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00